Table: Zeria Pharm -2019/20 group results
May 21 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2020 Mar 31, 2019 Mar 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 60.43 61.83
(-2.3 pct) (-4.2 pct)
Operating 4.09 3.74
(+9.6 pct) (-22.6 pct)
Recurring 3.88 3.30
(+17.7 pct) (-35.2 pct)
Net
Net 2.93 3.45
(-15.3 pct) (-16.9 pct)
EPS 62.62 yen 69.56 yen
Ann Div 34.00 yen 34.00 yen 34.00 yen
-Q2 Div 17.00 yen 17.00 yen 17.00 yen
-Q4 Div 17.00 yen 17.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T